CannaCor: Where Cannabis Cultivation and Blockchain Technology Combine Seamlessly CannaCor and Blockchain Corporation are collaborating with a common vision to bring lasting change in the field of cannabis research, cultivation, processing, and distribution. Our goal is to transform the entire cannabis cultivation process to make it as transparent and secure as possible. ...Read More

CannaCor: Where Cannabis Cultivation and Blockchain Technology Combine Seamlessly CannaCor and Blockchain Corporation are collaborating with a common vision to bring lasting change in the field of cannabis research, cultivation, processing, and distribution. 

Our goal is to transform the entire cannabis cultivation process to make it as transparent and secure as possible. - CannaCor (Pty) Ltd is an incorporated company under the Companies Act of 2011 in the Kingdom of Lesotho with Registration Number 65263 and TIN number 200084029-4. - CannaCor is licensed as a prohibited drug operator. The license is granted under Section 12 of the Drug Abuse Act of 2008 with license number 02/D022/06-2019. - CannaCor has obtained 50 000m2 of land in Berea, Lesotho, of which 30 000m2 is permitted for greenhouse or indoor cultivation of Cannabis. 

The vision of CannaCor is to become a frontrunner of medical cannabis cultivation in Lesotho. Our focus is to implement sustainable production facilities and expand our lead with an aquaponics production plant while integrating all our management systems with a selection of blockchain technologies to ensure transparency, immutability and real-life tracking Cannacor’s objective is to develop its own aquaponics cultivation and production facility for medical cannabis on the company’s premises in Lesotho. 

This will enable the company to meet growing demand in a global market of scarce production capacity and become a recognized supplier to the global markets that have no or limited production capacity. The intention is to establish a facility where standardized, uniform and consistent products can be cultivated, without the use of pesticides, so that the content of the active ingredients is the same for each harvesting and processing stage. 

The development of the cultivation premises into a complete facility for the cultivation and production of medical cannabis is expected to commence in the fourth quarter of 2019.